I do understand the different licenses , looked into, researched, and follow a number of Cannabis companies. I don't disagree that the license acquired with the purchase of Medcan is indeed valuable, I do however have issue with the overall value attributed to the 45% interest in MCL and how they derived it.
- Forums
- ASX - By Stock
- CGB
- Ann: Q&A on the merger of QBL MCL and Medcan
Ann: Q&A on the merger of QBL MCL and Medcan, page-322
-
- There are more pages in this discussion • 227 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online